| Akta Patel Mukherjee, MD | |
|
2384 Colony Crossing Pl, Midlothian, VA 23112-4280 | |
| (804) 423-3636 | |
| (804) 423-3637 |
| Full Name | Akta Patel Mukherjee |
|---|---|
| Gender | Female |
| Speciality | Endocrinology |
| Experience | 21 Years |
| Location | 2384 Colony Crossing Pl, Midlothian, Virginia |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1619084753 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 0101243090 (Virginia) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bon Secours Richmond Community Hospital | Richmond, VA | Hospital |
| Bon Secours St Francis Medical Center | Midlothian, VA | Hospital |
| Cjw Medical Center | Richmond, VA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Virginia Endocrinology And Osteoporosis Center | 1052377934 | 14 |
News Archive
Rutgers University's Cook Campus is buzzing with the news of a recent $750,000 U.S. Environmental Protection Agency (EPA) grant that will fund important and innovative research about biodiversity and West Nile Virus. Biodiversity, or the amount and variety of plants and animals in a geographic region, has become a major topic of interest in recent years.
CIDRAP News reports on a two-day meeting at the National Institutes of Health during which "researchers, biosecurity experts, and others" discussed the "crafting of a framework for funding H5N1 avian influenza gain-of-function studies." The meeting "is the latest chapter in an intense scientific controversy that was triggered by the publication of two recent studies involving lab-engineered H5N1 strains that showed signs of being transmissible in mammals," according to the news service.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
A British grandmother who died after being given a controversial and experimental cannabis-based medicine had apparently told her family that she thought the drug was driving her mad.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
› Verified 9 days ago
| Entity Name | Virginia Endocrinology And Osteoporosis Center |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871636449 PECOS PAC ID: 1052377934 Enrollment ID: O20041202000353 |
News Archive
Rutgers University's Cook Campus is buzzing with the news of a recent $750,000 U.S. Environmental Protection Agency (EPA) grant that will fund important and innovative research about biodiversity and West Nile Virus. Biodiversity, or the amount and variety of plants and animals in a geographic region, has become a major topic of interest in recent years.
CIDRAP News reports on a two-day meeting at the National Institutes of Health during which "researchers, biosecurity experts, and others" discussed the "crafting of a framework for funding H5N1 avian influenza gain-of-function studies." The meeting "is the latest chapter in an intense scientific controversy that was triggered by the publication of two recent studies involving lab-engineered H5N1 strains that showed signs of being transmissible in mammals," according to the news service.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
A British grandmother who died after being given a controversial and experimental cannabis-based medicine had apparently told her family that she thought the drug was driving her mad.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Akta Patel Mukherjee, MD 2384 Colony Crossing Pl, Midlothian, VA 23112-4280 Ph: (804) 423-3636 | Akta Patel Mukherjee, MD 2384 Colony Crossing Pl, Midlothian, VA 23112-4280 Ph: (804) 423-3636 |
News Archive
Rutgers University's Cook Campus is buzzing with the news of a recent $750,000 U.S. Environmental Protection Agency (EPA) grant that will fund important and innovative research about biodiversity and West Nile Virus. Biodiversity, or the amount and variety of plants and animals in a geographic region, has become a major topic of interest in recent years.
CIDRAP News reports on a two-day meeting at the National Institutes of Health during which "researchers, biosecurity experts, and others" discussed the "crafting of a framework for funding H5N1 avian influenza gain-of-function studies." The meeting "is the latest chapter in an intense scientific controversy that was triggered by the publication of two recent studies involving lab-engineered H5N1 strains that showed signs of being transmissible in mammals," according to the news service.
Inhaled Nitric Oxide (iNO) is a drug approved by the Food and Drug Administration that is commonly used in term and near-term neonates who have severe respiratory failure caused by pulmonary hypertension. Over the last decade there have been multiple large studies trying to determine a clinical use for iNO in preterm neonates, but despite evidence of short-term benefit, this drug has not been shown to improve long-term outcomes in preemies.
A British grandmother who died after being given a controversial and experimental cannabis-based medicine had apparently told her family that she thought the drug was driving her mad.
Tiny particles of iron oxide could become tools for simultaneous tumor imaging and treatment, because of their magnetic properties and toxic effects against brain cancer cells. In mice, researchers from Emory University School of Medicine have demonstrated how these particles can deliver antibodies to implanted brain tumors, while enhancing tumor visibility via magnetic resonance imaging (MRI).
› Verified 9 days ago
Dr. Jennifer Simpliciano, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 611 Watkins Centre Pkwy Ste 250, Midlothian, VA 23114 Phone: 804-423-8470 Fax: 804-423-8471 | |
Dr. Vicki B Latham-solomon, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13901 Coalfield Commons Pl Ste 201, Midlothian, VA 23114 Phone: 804-420-1200 Fax: 804-344-0980 | |
Mark A Gentz, D.O. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 505, Midlothian, VA 23114 Phone: 804-601-0609 Fax: 804-594-7424 | |
Shashi Kumar Prabhakar, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 600, Midlothian, VA 23114 Phone: 804-794-6400 Fax: 804-897-0910 | |
Francesca Levine Glynn, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 510, Midlothian, VA 23114 Phone: 804-423-8470 Fax: 804-423-8471 | |
Morgan L. Vargo, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2384 Colony Crossing Pl, Midlothian, VA 23112 Phone: 804-423-3636 | |
Omar F Shams, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 13700 St Francis Blvd, Suite 600, Midlothian, VA 23114 Phone: 804-794-6400 Fax: 804-897-0910 |